Patents/Inventors

Guy Georges

PenzbergDE27 patents

20 Patents

US126007812026
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US125655362026
Method for Generating Avid-binding Multispecific Antibodies
Hoffmann-la Roche Inc.
0 cites
US122972632025
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US122972902025
Method for Generating Multispecific Antibodies from Monospecific Antibodies
Hoffmann-la Roche Inc.
0 cites
US122525332025
Anti-transferrin Receptor Antibodies with Tailored Affinity
Hoffmann-la Roche Inc.
0 cites
US122275942025
Bispecific 2+1 Contorsbodies
Hoffmann-la Roche Inc.
0 cites
US122151522025
Humanized Anti-human CD19 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US121459942024
Bispecific Antigen Binding Molecules Capable of Specific Binding to CD40 and to Fap
Hoffmann-la Roche Inc.
0 cites
US121039672024
Bispecific Anti-ccl2 Antibodies
Hoffmann-la Roche Inc.
0 cites
US120436512024
Compbody—a Multivalent Target Binder
Hoffmann-la Roche Inc.
0 cites
US120233782024
Covalently Linked Antigen-antibody Conjugates
Hoffmann-la Roche Inc.
0 cites
US118277112023
Antibodies Binding to NKG2D
Hoffmann-la Roche Inc.
0 cites
US118208162023
Anti-vegf Antibodies and Methods of Use
Hoffman-la Roche Inc.
0 cites
US117878732023
Bispecific HER2 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US117391422023
Bispecific Anti-ccl2 Antibodies
Hoffmann-la Roche Inc.
0 cites
US116801102023
Three-dimensional Structure-based Humanization Method
Hoffmann-la Roche Inc.
0 cites
US116739682023
Anti-brdu Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US116083762023
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US115847932023
Anti-transferrin Receptor Antibodies with Tailored Affinity
Hoffmann-la Roche Inc.
0 cites
US115724042023
Humanized Anti-tau(ps422) Antibodies and Methods of Use
Hoffman-la Rocher Inc.
0 cites